Maureen Killackey, MD, FACS, FACOG

After graduating from Barnard College, Columbia University, getting her MD at Cornell Weill Medical Center, training at New York Hospital and Memorial Sloan Kettering, Dr. Killackey has been immersed in cancer care delivery since 1982 when she started as a gynecologic/surgical oncologist. Since 2000, she has developed and directed multidisciplinary cancer programs affiliated with NCI-Comprehensive Cancer Centers (Memorial Sloan Kettering and Herbert Irving/Columbia University) in urban, rural and suburban settings. Most recently, as Professor of Medicine, Obstetrics and Gynecology at Columbia, she developed 2 ACOS-CoC community cancer programs for the Columbia/Irving Cancer Center. She is a peer reviewer for multiple medical journals, grants reviewer for the National Cancer Institute, Susan B. Komen, and others, and on the External Advisory Board for the George Washington University Survivorship PCORI grants. She contributes to the efforts of the American Cancer Society (ACS), Society of Gynecologic Oncology (SGO), the American College of Obstetrics and Gynecology (ACOG), American College of Surgeons (ACOS), and is a national cancer program site reviewer for the ACOS-Commission on Cancer (COC). She is Chair of the NYS Cancer Advisory Council, leader of the NYS Survivorship Action Team, HPV Vaccination Coalition and contributed to the CDC-NYS Comprehensive Cancer Plans 2012 -2017 and 2018-2022. In these activities, she has leadership roles to support national goal of “80% in every community” for colorectal cancer screening, increasing the uptake of the HPV vaccine and cancer survivorship initiatives. These academic-community partnerships, integrated with regional and local resources have been successful collaborations. Her efforts reflect Dr. Killackey’s commitment to ensure diverse communities’ access to the highest quality of patient-centered, multidisciplinary and coordinated oncology services along the continuum of cancer care from screening, prevention through diagnosis and treatment and into survivorship.